We are live on ! Find out more
NKGNW

NKGen Biotech, Inc. Warrants
NKGNW

Delisted

NKGNW was delisted on the 4th of March, 2025.

Back to rankings

29 hedge funds and large institutions have $159K invested in NKGen Biotech, Inc. Warrants in 2024 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 4

6% less funds holding

Funds holding: 31 → 29 (-2)

29% less capital invested

Capital invested by funds: $224K → $159K (-$64.6K)

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

Holders
29
Holders Change
-2
Holders Change %
-6.45%
% of All Funds
0.42%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
4
Reduced
4
Closed
2
Calls
$2K
Puts
–
Net Calls
+$2K
Net Calls Change
-$1K

Top Buyers

Rank Fund Capital Flow
1
CAC
Cowen and Company
New York
+$4.28K
2
SFA
Sequoia Financial Advisors
Ohio
+$2.77K
3
BOCH
Blue Owl Capital Holdings
New York
+$2.68K
4
Citadel Advisors
Citadel Advisors
Florida
+$98
5
UBS Group
UBS Group
Switzerland
+$83

Top Sellers

Rank Fund Capital Flow
1
KL
KIM LLC
Kansas
-$9.11K
2
EAM
Exos Asset Management
New York
-$5.18K
3
PC
Periscope Capital
Ontario, Canada
-$1.89K
4
FTUS
Flow Traders U.S.
New York
-$260
5
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$184
Name Holding Trade Value Shares
Change 		Change in
Stake
RCM
1
Rivernorth Capital Management
Florida
$46.1K – – –
Adage Capital Partners
2
Adage Capital Partners
Massachusetts
$11.3K -$184 -2,059 -1%
BNP Paribas Financial Markets
3
BNP Paribas Financial Markets
France
$10.6K – – –
Balyasny Asset Management
4
Balyasny Asset Management
Illinois
$9.89K – – –
SCM
5
Shaolin Capital Management
Florida
$9.07K – – –
Jane Street
6
Jane Street
New York
$7.08K – – –
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
7
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
$7.07K – – –
EAM
8
Exos Asset Management
New York
$6.25K -$5.18K -57,900 -40%
CAC
9
Cowen and Company
New York
$6.2K +$4.28K +47,917 +120%
TCA
10
Taconic Capital Advisors
New York
$4.95K – – –
PAMP
11
Polar Asset Management Partners
Ontario, Canada
$4.24K – – –
D.E. Shaw & Co
12
D.E. Shaw & Co
New York
$3.54K – – –
Walleye Capital
13
Walleye Capital
New York
$3.25K – – –
SFA
14
Sequoia Financial Advisors
Ohio
$3.19K +$2.77K +31,027 +220%
MTCM
15
Mint Tower Capital Management
Netherlands
$3K – – –
AIMCA
16
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$2.83K – – –
FBCM
17
Fort Baker Capital Management
California
$2.61K – – –
SCM
18
Saba Capital Management
New York
$2.2K – – –
SSA
19
Schonfeld Strategic Advisors
New York
$2.12K – – –
BOCH
20
Blue Owl Capital Holdings
New York
$2.1K +$2.68K +30,000 New
WAM
21
Wolverine Asset Management
Illinois
$1.97K -$25 -281 -1%
Citadel Advisors
22
Citadel Advisors
Florida
$1.95K +$98 +1,100 +4%
Walleye Trading
23
Walleye Trading
New York
$1.83K – – –
GCIA
24
Gabelli & Co Investment Advisers
New York
$1.22K – – –
GF
25
Gabelli Funds
New York
$1.22K – – –
1
2

NKGNW Hedge Fund Activity: Q3 2024 in Review

29 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in NKGen Biotech, Inc. Warrants (NKGNW) for Q3 2024, worth a combined $159K — down 29% from $224K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of NKGNW and 1 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 4 added.

The largest buyer was Cowen and Company, adding an estimated $4.28K. The largest seller was KIM LLC, exiting entirely with an estimated $9.11K sold.

  • 29 institutional investors held NKGen Biotech, Inc. Warrants (NKGNW) as of Q3 2024, down from 31 in Q2 2024.
  • Funds reported $159K of NKGen Biotech, Inc. Warrants stock for Q3 2024, down 29% quarter-over-quarter.
  • 1 fund opened new NKGen Biotech, Inc. Warrants positions in Q3 2024 and 2 closed out, a net change of -1 holder.
  • The largest NKGen Biotech, Inc. Warrants buyer in Q3 2024 was Cowen and Company, an estimated $4.28K added.
  • The largest NKGen Biotech, Inc. Warrants seller in Q3 2024 was KIM LLC, an estimated $9.11K sold.

Based on aggregated 13F filings for Q3 2024.